JMIR Cancer

Patient-centered innovations, education, and technology for cancer care, cancer survivorship, and cancer research.

Editor-in-Chief:

Naomi Cahill, PhD, RD, Editor-in-Chief; Scientific Editor at JMIR Publications, Canada


Impact Factor 3.3 CiteScore 4.1

JMIR Cancer (JC, ISSN: 2369-1999) is a peer-reviewed journal focusing on education, innovation and technology in cancer care, cancer survivorship and cancer research, and participatory and patient-centred approaches. This journal also includes research on non-Internet approaches to improve cancer care and cancer research.

We invite submissions of original research, viewpoints, reviews, tutorials, case studies, and non-conventional articles (e.g. open patient education material and software resources that are not yet evaluated but are free for others to use/implement). 

In our "Patients' Corner," we invite patients and survivors to submit short essays and viewpoints on all aspects of cancer. In particular, we are interested in suggestions on improving the health care system and suggestions for new technologies, applications and approaches (this section has no article processing fees).

In 2024, JMIR Cancer received a Journal Impact Factor™ of 3.3 (Source: Journal Citation Reports™ from Clarivate, 2024). JMIR Cancer is indexed in PubMed Central and PubMedScopusDOAJ, MEDLINE, and the Emerging Sources Citation Index (Clarivate). With a CiteScore of 4.1, JMIR Cancer is a Q2 journal in the field of Oncology, according to Scopus data.

Recent Articles

Article Thumbnail
Cancer Epidemiology, Cancer Surveillance and Infodemiology

Cancers of the bladder, kidney, and prostate are the 3 major genitourinary cancers that significantly contribute to the global burden of disease (GBD) and continue to show increasing rates of morbidity and mortality worldwide. In mainland China, understanding the cancer burden on patients and their families is crucial; however, public awareness and concerns about these cancers, particularly from the patient’s perspective, remain predominantly focused on financial costs. A more comprehensive exploration of their needs and concerns has yet to be fully addressed.

|
Article Thumbnail
Reviews on Innovations in Cancer

The relationship between assisted reproductive technology (ART) and childhood cancer risk has been widely debated. Previous meta-analyses did not adequately account for the impact of infertility, and this study addresses this gap.

|
Article Thumbnail
Cancer Epidemiology, Cancer Surveillance and Infodemiology

The non-invasive imaging examinations of mammography (MG), low-dose CT for lung cancer screening (LCS) and CT colonography (CTC) play important roles in screening for the most common cancer types. Internet search data can be used to gauge public interest in screening techniques, assess common screening-related questions and concerns, and formulate public awareness strategies.

|
Article Thumbnail
Breast Cancer

Breast cancer is prevalent among females in the United States. Non-metastatic disease is treated by partial or complete Mastectomy procedures. However, the rates of those procedures vary across practices. Generating real-world evidence on breast cancer surgery could lead to improved and consistent practices. We investigated the quality of data from the All of Us Research Program, which is a precision medicine initiative that collected real-world electronic healthcare data from different sites in the United States both retrospectively and prospectively to participant enrollment.

|
Article Thumbnail
Chemotherapy and Side Effects Management

Androgen receptor axis-targeting reagents (ARATs) have become key drugs for patients with castration-resistant prostate cancer (CRPC). ARATs are taken long term in outpatient settings, and effective adverse event (AE) monitoring can help prolong treatment duration for patients with CRPC. Despite the importance of monitoring, few studies have identified which AEs can be captured and assessed in community pharmacies, where pharmacists in Japan dispense medications, provide counseling, and monitor potential AEs for outpatients prescribed ARATs. Therefore, we anticipated that a named entity recognition (NER) system might be used to extract AEs recorded in pharmaceutical care records generated by community pharmacists.

|
Article Thumbnail
Mobile Apps for Cancer Care and Cancer Prevention and Screening

Digital interventions for supportive care during cancer treatment incorporating electronic patient-reported outcomes (ePROs) can enhance early detection of symptoms and facilitate timely symptom management. However, economic evaluations are needed.

|
Article Thumbnail
Innovations and Technology in Cancer Care

People with advanced ovarian cancer and their caregivers report unmet supportive care needs. We developed a Collaborative Agenda-Setting Intervention (CASI) to elicit patients’ and caregivers’ needs through the patient portal prior to a clinic visit and to communicate these needs to clinicians using the electronic health record.

|
Article Thumbnail
Viewpoints on Innovations in Cancer Care and Research

Therapist-guided eHealth interventions have been shown to engage users more effectively and achieve better outcomes than self-guided interventions when addressing psychological symptoms. Building on this evidence, this viewpoint aimed to describe the adaptation of iConquerFear, a self-guided eHealth intervention targeting fear of cancer recurrence, into a therapist-guided version (TG-iConquerFear) tailored specifically for colorectal cancer survivors (CRCS). The goal was to optimize patient outcomes while minimizing the need for extensive resources. The adaptation process followed the Information System Research Framework, which facilitated a systematic integration of knowledge and iterative testing. Drawing on insights from the original iConquerFear development, as well as feedback from end-users, oncologists, and therapists, we began by identifying areas for improvement. These insights formed the foundation for the first design cycle. Initial internal testing revealed the need for several adjustments to enhance the intervention. While the core concept of iConquerFear remained unchanged, we made significant modifications to improve access by optimizing the platform for mobile devices, to support adherence by expanding the exercises, and to equip therapists with tools such as reflective questions and a monitoring control panel. External field testing with five CRCS provided further validation. Participants reported a high level of acceptability, and their feedback guided additional minor to consider incorporating in future versions. This study illustrates how a self-guided eHealth intervention can be successfully adapted into a therapist-guided format for fear of cancer recurrence, tailored to meet the needs of CRCS. The described approach serves as a valuable framework for integrating therapist guidance into similar interventions, ensuring their relevance and effectiveness for targeted populations.

|
Article Thumbnail
Cancer Survivorship

Though telehealth has been a promising avenue for engaging cancer survivors with health care and lifestyle programming, older and rural-dwelling cancer survivors may have additional challenges to accessing digital devices and tools that have not yet been described. This study aims to utilize a robust, nationally representative sample collected in 2022 to provide an updated view of digital technology use and use of technology for health in this population.

|
Article Thumbnail
Breast Cancer

Breast cancer is a major health concern in various countries. Routine mammography screening has been shown to reduce breast cancer mortality, and Japan has set national targets to improve screening participation and increase public attention. However, collecting nationwide data on public attention and activity is not easy. Google Trends can reveal changes in societal interest, yet there are no reports on the relationship between Internet search volume and nationwide participation rates in Japan.

|

We are working in partnership with